Eventide Asset Management »

Rapport Therapeutics shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.3M 110k 20.48
2024-06-30 $1.2M 50k 23.26